6th Antifibrotic Drug Development Summit (AFDD)
Evvnt Promotion / evvnt
Archivio
09.11.2022 - 11.11.2022 Crowne Plaza Boston - Woburn, an IHG Hotel, 15 Middlesex Canal Park Rd, 01801 Woburn, USA
Time: 8:25 am to 5:00 pm
Temi della conferenza
Returning for the 6th year, the Antifibrotic Drug Development Summit (AFDD) will host the transferrable insights you need from IPF, NASH, CKD and more in one place at one time, so you can advance the progress of your antifibrotic therapies.
Returning for the 6th year, the Antifibrotic Drug Development Summit (AFDD) will host the transferrable insights you need from IPF, NASH, CKD and more in one place at one time, so you can advance the progress of your antifibrotic therapies.
Scientific organizer
Hanson Wade
Hanson Wade
Annotazioni
Speakers: Adi Mor Chief Scientific Officer Chemomab, Akshay Krishnamurty Senior Scientist, Cancer Immunology Genentech, Andrew Leask Professor University of Saskatchewan, Andrzej Krolewski Senior Investigator Joslin Diabetes Centre
Speakers: Adi Mor Chief Scientific Officer Chemomab, Akshay Krishnamurty Senior Scientist, Cancer Immunology Genentech, Andrew Leask Professor University of Saskatchewan, Andrzej Krolewski Senior Investigator Joslin Diabetes Centre
Informazioni ed Iscrizioni:
https://go.evvnt.com/1241066-2?pid=4832
Ms. Jessica Durston
Servizi sanitari
Lingua
Inglese
Inglese
Quote del Congresso
USD 2199.00 - USD 5696.00
USD 2199.00 - USD 5696.00
I partecipanti attesi
1000
1000
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."
